Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- 14 January 2021
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 384 (2), 105-116
- https://doi.org/10.1056/nejmoa2025797
Abstract
The selective cardiac myosin activator omecamtiv mecarbil has been shown to improve cardiac function in patients with heart failure with a reduced ejection fraction. Its effect on cardiovascular outcomes is unknown.Keywords
Funding Information
- Amgen
- Cytokinetics Inc.
- Servier
This publication has 23 references indexed in Scilit:
- Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trialThe Lancet, 2016
- Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart FailureJournal of the American College of Cardiology, 2016
- Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyThe Lancet, 2011
- The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialThe Lancet, 2011
- Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart FailureScience, 2011
- Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction: A Meta-Analytic ApproachJournal of the American College of Cardiology, 2010
- Improvement of Cardiac Function by a Cardiac Myosin Activator in Conscious Dogs With Systolic Heart FailureCirculation: Heart Failure, 2010
- A graphical approach to sequentially rejective multiple test proceduresStatistics in Medicine, 2008
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Repeated assessment of results in clinical trials of cancer treatmentThe British Journal of Radiology, 1971